Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) insider Derek J. Maetzold sold 1,947 shares of the business’s stock in a transaction that occurred on Friday, April 12th. The shares were sold at an average price of $20.35, for a total value of $39,621.45. Following the completion of the transaction, the insider now directly owns […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 9,152 shares of the business’s stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $21.45, for a total value of $196,310.40. Following the completion of the sale, the director now directly owns 22,782 shares of […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) Director Daniel Bradbury sold 9,152 shares of Castle Biosciences stock in a transaction that occurred on Thursday, April 4th. The stock was sold at an average price of $21.45, for a total value of $196,310.40. Following the transaction, the director now owns 22,782 shares in the company, […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 1,420,000 shares, an increase of 17.4% from the February 29th total of 1,210,000 shares. Based on an average daily trading volume, of 252,100 shares, the short-interest […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) was the target of a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 1,240,000 shares, a growth of 29.3% from the January 15th total of 958,800 shares. Currently, 5.0% of the company’s shares are short sold. […]